N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.168 NOK 1.59% Market Closed
Market Cap: 708m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Nykode Therapeutics ASA
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nykode Therapeutics ASA
Interest Income Expense Peer Comparison

Comparables:
HBC
B
BGBIO
L
LYTIX
AZT
T
TRMED

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
N
Nykode Therapeutics ASA
OSE:NYKD
Interest Income Expense
$11m
CAGR 3-Years
140%
CAGR 5-Years
178%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Interest Income Expense
-kr248k
CAGR 3-Years
70%
CAGR 5-Years
24%
CAGR 10-Years
25%
B
Bergenbio ASA
OSE:BGBIO
Interest Income Expense
kr6.8m
CAGR 3-Years
14%
CAGR 5-Years
47%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Interest Income Expense
kr8.9m
CAGR 3-Years
143%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Interest Income Expense
kr10.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
26%
T
Thor Medical ASA
OSE:TRMED
Interest Income Expense
kr1.6m
CAGR 3-Years
N/A
CAGR 5-Years
-29%
CAGR 10-Years
-3%

See Also

What is Nykode Therapeutics ASA's Interest Income Expense?
Interest Income Expense
11m USD

Based on the financial report for Jun 30, 2024, Nykode Therapeutics ASA's Interest Income Expense amounts to 11m USD.

What is Nykode Therapeutics ASA's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
178%

Over the last year, the Interest Income Expense growth was 54%. The average annual Interest Income Expense growth rates for Nykode Therapeutics ASA have been 140% over the past three years , 178% over the past five years .

Back to Top